Anxiety News and Research

Latest Anxiety News and Research

DEA issues new guideline to ease delay in prescriptions for nursing home residents

The Drug Enforcement Administration has issued a new guideline intended to help ease the delay some nursing home residents face in receiving certain painkillers and anti-anxiety medications.

8 Oct 2010

First Edition: October 7, 2010

Today's headlines include stories on waivers given some companies that offer only minimal health insurance coverage, insurers' political efforts during this campaign season and efforts in New York to bar the use of food stamps to buy soda.

7 Oct 2010

Majority of cancer patients are concerned about treatment costs: MDLinx

Ninety five percent of the nation's oncologists report a rise in their patients' concerns over treatment costs in the past six months, according to a survey conducted by MDLinx, one of the U.S.'s largest doctor portals.

7 Oct 2010

NIH grants $3.7 million to develop more accurate algorithms for tracking fetal development

Fetal growth is used as a marker of health and well-being in unborn babies as well as children. But, the tools that are currently available to differentiate between a small, healthy fetus and a fetus that is small due to pathologic causes have significant limitations. What if they were improved. Would it save the health care system resources spent monitoring women who might need medical intervention because their fetuses might just be small and healthy. Would it help some women avoid the anxiety such intervention brings.

7 Oct 2010

Herbal supplements can treat anxiety disorders

A systematic review of research into the use of nutritional supplements for the treatment of anxiety disorders has found strong evidence for the use of extracts of passionflower or kava and combinations of L-lysine and L-arginine. Researchers writing in BioMed Central's open access Nutrition Journal pooled the results of 24 studies involving a total of more than 2000 participants, showing that some nutritional and herbal supplements can be effective, without the risk of serious side effects.

7 Oct 2010

Fisher Wallace Laboratories launches easy-to-use medical device for depression treatment

Fisher Wallace Laboratories today announced the launch of a bold YouTube video campaign that challenges the pharmaceutical drug industry and introduces the company's easy-to-use medical device prescribed for the self-treatment of depression: the Fisher Wallace Cranial Stimulator.

6 Oct 2010

Researchers to conduct trial to improve drug abstinence, relapse rates

A $15.7 million award from the National Institute on Drug Abuse (NIDA) is allowing researchers to see whether consistent exercise will help people abstain from stimulant abuse.

6 Oct 2010

Aeterna Zentaris' AEZS-130 demonstrates potential as oral diagnostic test for AGHD

Aeterna Zentaris Inc., today announced that an interim review of a Phase 3 trial of AEZS-130 (macimorelin, SolorelTM), demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The data was presented earlier today by Beverly M.K. Biller, M.D. of the Harvard Medical School/Massachusetts General Hospital in Boston, at the 5th International Congress of the Growth Hormone Research Society (GRS) and the Insulin-like Growth Factors (IGF) Society in New York City.

6 Oct 2010

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

The Belgian biotech company Galapagos has won the 2010 EUROPEAN BIOTECHNICA AWARD. Galapagos thus secures the lion's share of the prize money totalling 75,000 euros, which is offered every year in the competition staged by Deutsche Messe AG and its partners. The award celebrates innovative European companies from the biotechnology sector and the life sciences.

5 Oct 2010

Study: 18% of children with ADHD suffered from depression as adolescents

Children diagnosed with attention deficit/hyperactivity disorder (ADHD) at ages 4 to 6 are more likely to suffer from depression as adolescents than those who did not have ADHD at that age, according to a long-term study published in the October issue of the Archives of General Psychiatry. Although it was an uncommon occurrence, the children with ADHD also were somewhat more likely to think about or attempt suicide as adolescents.

5 Oct 2010

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Oct 2010

Healthcare system does not take girls with autism or ADHD symptoms seriously

When girls with symptoms of autism or ADHD seek professional medical help, their problems are often played down or misinterpreted, and there is a real risk that they will not get the help or support they need. As such, more training is needed in this area, particularly in the public sector, reveals a thesis from the University of Gothenburg.

4 Oct 2010

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for tapentadol extended release tablets.

4 Oct 2010

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

4 Oct 2010

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.

4 Oct 2010

New SymPath kit measures DBH activity of Sympathetic Nervous System

Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.

4 Oct 2010

Swedish Medical Center researcher receives NIH grants to study pregnancy complications

Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.

1 Oct 2010

Family and friends may pose the greatest threat to caregivers' health and well-being

The biggest cause of stress for people who care for loved ones after a stroke may not be worrying about the affected family member.

1 Oct 2010

Legal storm brews in area of mental health protection at work

Financial rewards for damages caused by mental injury at work have increased over the past five years by as much as 700%, according to a report released today by the Mental Health Commission of Canada (MHCC). The report warns that a perfect legal storm is brewing in the area of mental health protection at work, and points to emerging responsibilities for employers to provide a psychologically safe workplace. This is timely, since October is Canada's Healthy Workplace Month and next week is Mental Illness Awareness Week.

30 Sep 2010

New online CDSMP program launched to battle against chronic illnesses

Taking the battle against the national epidemic of chronic illnesses to the Internet, the National Council on Aging (NCOA) is making Better Choices, Better Health, the online version of the internationally recognized Chronic Disease Self Management Program (CDSMP), available free for people in California and six other states Hawaii, Iowa, Maine, Massachusetts, New Jersey, and Oregon.

30 Sep 2010

Anxiety News and Research

Latest Anxiety News and Research

DEA issues new guideline to ease delay in prescriptions for nursing home residents

First Edition: October 7, 2010

Majority of cancer patients are concerned about treatment costs: MDLinx

NIH grants $3.7 million to develop more accurate algorithms for tracking fetal development

Herbal supplements can treat anxiety disorders

Fisher Wallace Laboratories launches easy-to-use medical device for depression treatment

Researchers to conduct trial to improve drug abstinence, relapse rates

Aeterna Zentaris' AEZS-130 demonstrates potential as oral diagnostic test for AGHD

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

Study: 18% of children with ADHD suffered from depression as adolescents

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Healthcare system does not take girls with autism or ADHD symptoms seriously

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

New SymPath kit measures DBH activity of Sympathetic Nervous System

Swedish Medical Center researcher receives NIH grants to study pregnancy complications

Family and friends may pose the greatest threat to caregivers' health and well-being

Legal storm brews in area of mental health protection at work

New online CDSMP program launched to battle against chronic illnesses

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Anxiety News and Research

Latest Anxiety News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in